HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norihiro Watanabe Selected Research

Interleukins

6/2014Reversal of tumor immune inhibition using a chimeric cytokine receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norihiro Watanabe Research Topics

Disease

18Neoplasms (Cancer)
01/2022 - 01/2007
4Leukemia
01/2022 - 01/2008
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2020
2Breast Neoplasms (Breast Cancer)
11/2021 - 10/2018
2Graft vs Host Disease (Graft-Versus-Host Disease)
03/2021 - 01/2008
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 01/2017
1Testicular Neoplasms (Testicular Cancer)
01/2020
1Hemorrhage
01/2020
1Hematologic Diseases (Blood Diseases)
10/2018
1Head and Neck Neoplasms (Head and Neck Cancer)
11/2017
1Virus Diseases (Viral Diseases)
06/2011
1Residual Neoplasm
03/2011
1Hematologic Neoplasms (Hematological Malignancy)
01/2008
1Lymphoma (Lymphomas)
01/2008
1Carcinoma (Carcinomatosis)
01/2007
1Necrosis
01/2007

Drug/Important Bio-Agent (IBA)

11Chimeric Antigen ReceptorsIBA
01/2022 - 01/2016
7AntigensIBA
01/2022 - 01/2008
7CytokinesIBA
01/2020 - 06/2014
4Interleukin-4 (Interleukin 4)IBA
10/2018 - 06/2014
2Cytokine Receptors (Cytokine Receptor)IBA
10/2018 - 06/2014
2Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
10/2018 - 06/2014
2Interleukin-7 Receptors (Interleukin 7 Receptor)IBA
10/2018 - 06/2014
2Neoplasm Antigens (Tumor Antigens)IBA
06/2014 - 03/2011
2Peptides (Polypeptides)IBA
03/2011 - 04/2010
1Mucin-1 (CA 15-3 Antigen)IBA
11/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2021
1LigandsIBA
11/2021
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
11/2021
12-toluenesulfonamide (OTS)IBA
03/2021
1Cyclin A1IBA
01/2020
1CyclinsIBA
01/2020
1C-Type Lectins (C-Type Lectin)IBA
01/2020
1Interleukin-10 (Interleukin 10)IBA
01/2018
1Interleukin-13IBA
01/2018
1InterleukinsIBA
06/2014
1Indicators and Reagents (Reagents)IBA
01/2013
1RNA (Ribonucleic Acid)IBA
01/2013
1Messenger RNA (mRNA)IBA
01/2013
15- (2'- naphthyl)- 7- 4- chlorophenyl- (2,3,6,8- tetrahydro)pyrrolo- (3,4- e)(1,4)- diazepine- 6- thioxo- 8- (1H,7H)oneIBA
01/2008
1HLA-DR Antigens (HLA-DR)IBA
01/2008
1Interleukin-2 (IL2)IBA
01/2008
1Zoledronic Acid (Zometa)FDA Link
01/2008
15-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA
11/2007
1calcein AMIBA
11/2007
1Ethidium (Ethidium Bromide)IBA
01/2007
1Radiation-Sensitizing AgentsIBA
01/2007
1Acridine OrangeIBA
01/2007
1ApigeninIBA
01/2007
1FlavonoidsIBA
01/2007

Therapy/Procedure

4Therapeutics
03/2021 - 01/2016
4Immunotherapy
01/2021 - 11/2007
1Oncolytic Virotherapy
01/2021
1Hematopoietic Stem Cell Transplantation
01/2020